Proton Pump Inhibitor Treatment and Aspirin Improve Outcomes in Barrett Esophagus

Proton pump inhibitors (PPIs) administered in high doses and aspirin chemoprevention therapy additively improve health outcomes in patients with Barrett esophagus, according to research published in The Lancet.

https://www.clinicaladvisor.com/gastroenterology-information-center/esomeprazole-ppi-and-aspirin-improve-outcomes-in-barrett-esophagus/article/787834/

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *